Extensive fibromuscular dysplasia in a patient with Parkinson disease.
The cause of fibromuscular dysplasia is not known. Ergot derivatives have been reported as a potential causative agent. The anti-Parkinson medication pergolide is an ergot derivative, but an association between fibromuscular dysplasia and this drug has not been previously reported.
Wang
Thomas H
TH
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Mauro
Matthew
M
Jennette
J Charles
JC
Moll
Stephan
S
D005260:Female; D005352:Fibromuscular Dysplasia / Q000139:chemically induced / Q000473:pathology*; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy / Q000473:pathology*; D010479:Pergolide / Q000009:adverse effects / Q000627:therapeutic use
D010479:Pergolide